Hiroki Ito

Hiroki Ito

Auto-generated profile, based on publicly available information

Hiroki Ito

Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Urology
Verified
Journal Article
Closed access
HIHiroki Ito
Hiroki Ito
TKTakashi Kawahara
Takashi Kawahara
HTHideyuki Terao
Hideyuki Terao
TOTakehiko Ogawa
Takehiko Ogawa
MYMasahiro Yao
Masahiro Yao
JMJunichi Matsuzaki
Junichi Matsuzaki

13 August 2014 in BJU International
Verified
Journal Article
Closed access
PDF file
HIHiroki Ito
Hiroki Ito
KSKentaro Sakamaki
Kentaro Sakamaki
TKTakashi Kawahara
Takashi Kawahara
HTHideyuki Terao
Hideyuki Terao
KYKengo Yasuda
Kengo Yasuda
JMJunichi Matsuzaki
Junichi Matsuzaki

1 September 2012 in Journal of Endourology
Verified
Journal Article
Closed access
HIHiroki Ito
Hiroki Ito
TKTakashi Kawahara
Takashi Kawahara
HTHideyuki Terao
Hideyuki Terao
TOTakehiko Ogawa
Takehiko Ogawa
MYMasahiro Yao
Masahiro Yao
JMJunichi Matsuzaki
Junichi Matsuzaki
Purpose: To assess the utility of attenuation coefficients as predictors of surgical outcome after a single flexible ureteroscopy (URS) with holmium laser lithotripsy. Many reports indicate that the efficacy of extracorporeal shockwave lithotripsy (SWL) can be predicted by the target's radiofrequency attenuation, measured as Hounsfield units (HUs) on noncontrast CT (NCCT). Studies of flexible URS, however, have not assessed the predictive value of attenuation coefficients on NCCT. Patients and Methods: Patients with renal stones who were treated by flexible URS with holmium laser lithotripsy between December 2009 and October 2011 at a single institute were retrospectively evaluated. Stone-free (SF) status was determined by kidneys-ureters-bladder (KUB) radiography at postoperative month 3. Correlations of possible predictors with SF status were analyzed using a logistic regression model. The comparison between groups with low and high HUs was examined using the Mann-Whitney U test. Results: There were 219 eligible procedures. According to the logistic regression model, the maximum attenuation coefficient (P=0.105) and average attenuation coefficient (P=0.175) did not significantly, independently predict SF status. Fragmentation efficiency was significantly different between cases with low and high attenuation coefficients (P=0.001). In groups with less than 20.0-mm diameter stones, overall operative time (P<0.001 and P=0.001) and the time from starting fragmentation (P<0.001 and P=0.002) were significantly high in both attenuation groups. In groups with stones greater than 20.0 mm diameter, the two definitions of operative time revealed no differences between the low and high attenuation groups. The retrospective study design was the major limitation of this study. Conclusions: We found that both the maximum and average attenuation coefficients on NCCT are significantly related to the fragmentation efficiency. In addition, this study showed that, in patient groups with stone a burden <20.0 mm in diameter, both the maximum and average attenuation coefficients were significantly predictive of operative time.

18 September 2017 in BMC Urology
Verified
Journal Article
Open access
PDF file
YSYoko Saitoh-Maeda
Yoko Saitoh-Maeda
TKTakashi Kawahara
Takashi Kawahara
YMYasuhide Miyoshi
Yasuhide Miyoshi
STSohgo Tsutsumi
Sohgo Tsutsumi
DTDaiji Takamoto
Daiji Takamoto
HUHiroji Uemura
Hiroji Uemura
Recently, sarcopenia has been reported as a new predictor for patient outcomes or likelihood of post-operative complications. The purpose of this study was to evaluate the association of the psoas muscle volume with the length of hospitalization among patients undergoing radical cystectomy. A total of 63 (80.8%) male patients and 15 (19.2%) female patients who underwent radical cystectomy for their bladder cancer in our institution from 2000 to 2015 were analyzed. The psoas muscle index (PMI) was calculated by normalizing the psoas muscle area calculated using axial computed tomography at the level of the umbilicus (cm2) by the square of the body height (m2). Longer hospitalization was defined as hospitalization exceeding 30 days after surgery. The median PMIs (mean ± standard deviation) were 391 (394 ± 92.1) and 271 (278 ± 92.6) cm2/m2 in men and women, respectively. Thus, the PMIs of male patients were significantly larger than those of females (p < 0.001). Based on the differences in gender, we analyzed 63 male patients for a further analysis. In male patients, those hospitalized longer showed a significantly smaller PMI than those normally discharged (377 ± 93.1 vs. 425 ± 83.4; p = 0.04). Similarly, male patients with a small PMI (<400) had a significantly worse overall survival (p = 0.02) than those with a large PMI (≥400). The presence of sarcopenia was found to be associated with significantly longer hospitalization after radical cystectomy in male patients. Furthermore, in men, a PMI <400 may suggest a significantly worse prognosis.

5 March 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
TKTakashi Kawahara
Takashi Kawahara
KFKazuhiro Furuya
Kazuhiro Furuya
MNManami Nakamura
Manami Nakamura
KSKentaro Sakamaki
Kentaro Sakamaki
KOKimito Osaka
Kimito Osaka
HUHiroji Uemura
Hiroji Uemura
There is no reliable biomarker for predicting the prognosis of patients who undergo radical cystectomy for bladder cancer. Recent studies have shown that the neutrophil-to-lymphocyte ratio (NLR) could function as a useful prognostic factor in several types of malignancies. This study aimed to assess the usefulness of NLR in bladder cancer. A total of 74 patients who underwent radical cystectomy in our institutions from 1999 to 2014 were analyzed. The NLR was calculated using the patients’ neutrophil and lymphocyte counts before radical cystectomy. An immunohistochemical analysis was also performed to detect tumor infiltrating neutrophils (CD66b) and lymphocytes (CD8) in bladder cancer specimens. A univariate analysis showed that the patients with a high NLR (≥2.38; HR = 4.84; p = 0.007), high C-reactive protein level (>0.08; HR = 10.06; p = 0.030), or pathological lymph node metastasis (HR = 4.73; p = 0.030) had a significantly higher risk of cancer-specific mortality. Kaplan-Meier and log-rank tests further revealed that NLR was strongly correlated with overall survival (p = 0.018), but not progression-free survival (p = 0.137). In a multivariate analysis, all of these were found to be independent risk factors (HR = 4.62, 10.8, and 12.35, respectively). The number of CD8-positive lymphocytes was significantly increased in high-grade (p = 0.001) and muscle-invasive (p = 0.012) tumors, in comparison to low-grade and non-muscle-invasive tumors, respectively. The NLR predicted the prognosis of patients who underwent radical cystectomy and might therefore function as a reliable biomarker in cases of invasive bladder cancer.

7 July 2016 in BMC Cancer
Verified
Journal Article
Open access
PDF file
JKJun Kasuga
Jun Kasuga
TKTakashi Kawahara
Takashi Kawahara
DTDaiji Takamoto
Daiji Takamoto
SFSachi Fukui
Sachi Fukui
TTTakashi Tokita
Takashi Tokita
HUHiroji Uemura
Hiroji Uemura
The neutrophil-to-lymphocyte ratio (NLR), a simple marker of the systemic inflammatory response, has been demonstrated to correlate with patient outcomes for various solid malignancies. We investigated the utility of the pretreatment NLR as a prognosticator in patients who presented with penile cancer. A total of 41 patients who underwent complete blood count with differential and subsequent radical penectomy from 1988 to 2014 were analyzed. We assessed the correlation between the NLR and the prognosis of penile cancer. The median and mean (± SD) NLRs in 41 penile cancer patients were 3.42 and 5.03 ± 4.99, respectively. Based on the area under receiver operator characteristic curve, the cut-off value of NLR was determined to be 2.82. Patients with a high NLR (≥2.82) showed a significantly poorer cancer-specific survival (p = 0.023) than those with a low NLR. The pretreatment NLR may function as a biomarker that precisely predicts the prognosis in patients with penile cancer.